Showing 588 Results
How Is the Multiple Sclerosis Community Engaging on Value Assessment?
NPC President Dan Leonard caught up this week for a Q&A with Lisa Skutnik, President of the MS Coalition, to discuss how the value of multiple sclerosis (MS) treatments is being assessed,…
When Is It Less Acceptable for Patients to Face Higher Cost-Sharing?
A new study explores when variation in consumer cost-sharing makes sense, and when it is less acceptable for patients with the same or similar conditions to have different out-of-pocket costs, as…
Missed Signals in Cancer Care: Strategies to Address Quality Measure Gaps
When it comes to designing accountable care models, the dramatically varied needs and preferences of patients with cancer can confound quality measurement, especially when compounded by increasingly…
FDA Releases Guidance Documents on Communicating Clinical and Economic Information
The Food and Drug Administration (FDA) this week has released a series of draft guidance documents that clarify how and when different types of clinical and economic information may be communicated.
Pharmacy Benefits: Super-sized, Minimized or Right-Sized?
In the December issue of Employee Benefit News, NPC Vice President of Comparative Effectiveness Research Jennifer Graff, PharmD, outlines a framework for the consideration of treatment flexibility in…
Pre-Approval Information Exchange Can Help Improve Population Health Decision-Making
Health care stakeholders, including NPC, gathered in September for a meeting hosted by the Academy of Managed Care Pharmacy to discuss potential ways to improve the exchange of information between…
NPC President Dan Leonard Speaks on Value Frameworks at BioNJ
As our health care system shifts from a focus on volume to value, a key question emerges: Who gets to define value? National Pharmaceutical Council (NPC) President Dan Leonard and other health…
Engaging With ICER: National Psoriasis Foundation Opens Up on Value Assessment
NPC President Dan Leonard chatted with Leah Howard, Vice President of Government Relations and Advocacy, National Psoriasis Foundation, about value assessment frameworks and how her organization is…
NPC’s Dr. Jennifer Graff Testifies Before FDA on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Devices
NPC Vice President for Comparative Effectiveness Research Jennifer Graff, PharmD, highlighted two key issues in her testimony at the Food and Drug Administration public hearing on manufacturer…
Can We Assess the Value of Personalized Medicine in Treating Cancer?
NPC President Dan Leonard spoke with Dr. Amy Miller, EVP, Personalized Medicine Coalition, about how targeted medicines will be considered in value assessment frameworks.
Why Assessing Value Is Important and Why It’s Important to Get It Right
Why is assessing value in health care important? Why is it important to do it right? These two questions were at the heart of an opening presentation that set the tone for the National Pharmaceutical…
How and Why Is Broader Exchange of Information Needed to Support Public Health and Delivery Reform?
On November 9-10, 2016, the Food and Drug Administration will host a stakeholder meeting to obtain input on how biopharmaceutical companies and others are allowed to exchange information, such as…
Accountable Care Models Offer Insights on Improving Patient Care
Treatment for chronic conditions account for most health costs in the United States. So as health care providers shift to innovative delivery models to provide value-based care while being held…
NPC Value Conference Sparks Dialogue to Define, Understand Value in Health Care
How do we measure the value of a medical intervention, its benefits to patients, and the associated costs to patients, payers and society as a whole. Hundreds of stakeholders gathered in-person and…
Putting Patients First® in the Value Equation: An Interview With the National Health Council’s Dr. Eleanor Perfetto
National Pharmaceutical Council President Dan Leonard caught up this week with Eleanor Perfetto, PhD, MS, Senior Vice President of Strategic Initiatives at the National Health Council (NHC), about…
Optimizing the Recipe for "Health Care Spending Pie": Finding the Most Effective Resource Allocation
Despite concerns about the growth of the health care spending pie, little attention has been paid to the spending upon slices within it, such as how is the money being spent, and how well?
NPC Submits Comments to Institute for Clinical and Economic Review on Its Value Assessment Framework
The National Pharmaceutical Council (NPC) today submitted comments to the Institute for Clinical and Economic Review (ICER) about ways to improve its value assessment framework.
Exploring Dynamic Cost-sharing Models in Value-Based Insurance Design
Dr. Mark Fendrick of the Values-Based Insurance Design Center believes there are alternatives to today's static tiered pricing system, instead proposing a dynamic pricing model that acknowledges…
Moving Value Frameworks From Fledgling to Functional
Defining value in health care – especially as our health system shifts its focus from rewarding the volume of services provided to rewarding the value of those services – is complex. It’s going to…
Are We Getting the Right Data to Make Individualized Health Decisions? Maybe.
Personalized medicine—an evolving field in which physicians use diagnostic tests to determine which medical treatments will work best for each patient—has transformed the lives of patients with…